Research

Dr. Yuexin Xu received a 2021 Young Investigator Award for her project "Transcriptomic single-cell and spatial mapping of immune cell infiltration and tumor-associated endothelial cell heterogeneity in renal cell carcinoma." Xu is based at the Fred Hutchinson Cancer Research Center in Seattle, Washington. We spoke with Xu about her work and what it could mean for people with kidney cancer.…

Dr. Jianjun Gao and Dr. Pavlos Msaouel received a 2021 Advanced Discovery Award for their project "Identification of tumor frameshift neoantigens to accurately predict response to immune checkpoint therapy in renal cell carcinoma." Both Gao and Msaouel are based at MD Anderson Cancer Center in Houston, Texas. We spoke with Gao and Msaouel about their work and what it could…

Dr. Cristiane Bergerot received a 2021 Focus Award: Psychosocial for her project "Redefining Quality of Life Assessments in Metastatic Renal Cell Carcinoma." Bergerot is based at the Instituto Unity de Ensino e Pesquisa, Centro De Cancer de Brasilia in Brazil. We spoke with Bergerot about her work and what it could mean for people with kidney cancer. https://www.kidneycancer.org/the-kidney-cancer-association-awards-1-375-million-to-seven-teams-of-researchers/ What is…

Dr. Toni Choueiri and Dr. Rizwan Romee received a 2021 Advanced Discovery Award for their project "Adoptive cytokine-induced memory-like NK cell therapy alone or in combination with avelumab for immunotherapy-refractory advanced renal cell carcinoma." Both Choueiri and Romee are based at the Dana-Farber Cancer Center in Boston, Massachusetts. We spoke with Choueiri and Romee about their work and what it…

https://www.kidneycancer.org/ask-the-experts-common-questions-about-kidney-cancer-and-covid-19/ We rounded up a few research highlights from the 2021 Congress of the European Society for Medical Oncology. COVID-19 vaccines do protect patients with cancer A number of studies presented at ESMO Congress 2021 reported that people with cancer have appropriate immune response to COVID-19 vaccination. Vaccine efficacy and safety was in question because cancer patients, who may have…

In this series, we take a look at what’s happening in kidney cancer each month! From treatments and clinical trials to genetic testing and government regulations, the KCA’s Medical Director, Sallie McAdoo, MS, CGC, will show you what’s new and why it matters. After a quiet July, kidney cancer is back in the headlines. This month, let’s discuss the approval…

Welcome to our series where we take a look at what’s happening in kidney cancer each month! From treatments and clinical trials to genetic testing and government regulations, the KCA’s Medical Director, Sallie McAdoo, MS, CGC, will show you what’s new and why it matters. This month’s update was pushed back a little so that I could include my insights…

We rounded up a few research highlights from the 2021 meeting of the American Society of Clinical Oncology (ASCO). https://www.youtube.com/watch?v=x1W9jDlO7cU Dr. Toni Choueiri discussed the results of the KEYNOTE-564 trial. A “quantum leap” in post-nephrectomy treatment Treatment with the immunotherapy pembrolizumab (Keytruda) after nephrectomy significantly reduced the risk of disease recurrence or death compared with treatment with placebo in people…

Welcome to our new series where we take a look at what’s happening in kidney cancer each month! From treatments and clinical trials to genetic testing and government regulations, the KCA’s Medical Director, Sallie McAdoo, MS, CGC, will show you what’s new and why it matters. This month, I’m excited to share a flurry of activity from multiple groups that…

Dr. Brian Rini, chief of Clinical Trials at Vanderbilt-Ingram Cancer Center (VICC) and Vice-Chair of the KCA's Medical Steering Committee explained the benefits and nuances of clinical trial participation in a Q & A at Momentum, VICC's digital magazine. Read an excerpt of the conversation below and find the full piece here. Q Why should a cancer patient participate in a…